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Summary 
Sympathetic neurons depend on nerve growth factor 
(NGF) for survival and die by apoptosis in its absence. 
We have investigated the pattern of expression of the 
Jun and Fos family of transcription factors in dying 
sympathetic neurons using antibodies specific for 
each family member. When sympathetic neurons are 
deprived of NGF, the level of c-Jun protein significantly 
increases, whereas the levels of the other members 
of the Jun and Fos family remain relatively constant. 
c-Jun also becomes more phosphorylated, probably 
on its amino terminal transactivation domain. When 
microinjected into sympathetiic neurons, an expres- 
sion vector for a c-Jun dominant negative mutant pro- 
tects them against NGF withdrawal-induced death, in- 
dicating that AP-1 activity is essential for neuronal cell 
death. Furthermore, overexpression of the full-length 
c-Jun protein is, in itself, sufficient to induce apoptosis 
in sympathetic neurons. 
Introduction 
In multicellular organisms, cell death by apoptosis occurs 
during normal development, tissue homeostasis, and the 
response to viral infection and plays an important role in 
all of these situations (Ellis et al., 1991; Raft, 1992; Raft 
et al., 1993). In the case of the developing mammalian 
nervous system, cell death is widespread, with approxi- 
mately 50% of the neurons produced by neurogenesis 
dying by apoptosis (Oppenheim, 1991). These programmed 
cell deaths (PCD) are regulated by factors, such as the 
neurotrophins, that promote the survival of specific popu- 
lations of neurons (Levi-Montalcini, 1987; Barde, 1989; 
Snider, 1994). According to the neurotrophin hypothesis 
(for a recent discussion, see Korsching, 1993), the neu- 
rons that innervate a particular target are produced in ex- 
cess and compete for limiting quantities of survival factor, 
which is produced in minute amounts by their target. 
Those neurons that do not obtain an adequate supply of 
survival factor die by apoptosis. This is thought to be a 
mechanism for correctly matching the number of innervat- 
ing neurons with the size of their target. 
Sympathetic neurons isolated from the superior cervical 
ganglion (SCG) of the rat have proved to be a particularly 
useful model system for studying PCD in the nervous sys- 
tem (Martin et al., 1988). During the development of the 
rat, all SCG neurons are postmitotic at birth, and 35% of 
these die between days 3 and 7 (Wright et al., 1983). SCG 
neurons can be isolated from P1 rats and will survive for 
extended periods in culture in the presence of nerve 
growth factor (NGF). When deprived of NGF, they die by 
apoptosis, and the majority of the cells are dead after 3 
days (Martin et al., 1988; Edwards et al., 1991 ; Deckwerth 
and Johnson, 1993; Edwards and Tolkovsky, 1994). An 
important observation was made by Martin et al. (1988), 
who discovered that inhibitors of transcription or protein 
synthesis greatly reduced the rate at which sympathetic 
neurons die in the absence of NGF. This result led to the 
hypothesis that the removal of survival factor induces a 
gene or set of genes encoding proteins that trigger or 
cause cell death (for a review, see Johnson and Deck- 
werth, 1993). Furthermore, a requirement for transcription 
and protein synthesis has proved to be a general feature 
of neuronal cell death induced by the withdrawal of survival 
signals and has been observed with several different ypes 
of neuron isolated from both the central and peripheral 
nervous systems (Oppenheim et al., 1990; Scott and Da- 
vies, 1990; D' Mello et al., 1993; Milligan et al., 1994). 
The observation that neuronal cell death and certain other 
types of PCD, such as the activation-induced eath of T 
cells (for references, see Liu et al., 1994 and Woronicz et 
al., 1994), require transcription and protein synthesis led 
to the notion that apoptosis is an active, gene-directed 
process, and that apoptotic cells actively participate in 
their own demise. However, it should be noted that tran- 
scription and protein synthesis are often not required for 
cells to undergo apoptosis (Martin, 1993; Jacobson et al., 
1994), suggesting that cell death effector proteins must 
preexist in many types of cells. 
We are investigating the molecular mechanisms under- 
lying mammalian neuronal cell death. In particular, we 
would like to understand the basis for the transcriptional 
requirement. For example, what genes are activated when 
sympathetic neurons are deprived of NGF? How are these 
genes regulated, and how do their products lead to cell 
death? As an initial step, we have chosen to investigate 
the pattern of expression of the Jun and Fos family of 
transcription factors. Since members of the Jun and Fos 
family have already been demonstrated to play important 
roles in cell proliferation and differentiation (Angel and 
Karin, 1991; Curran and Vogt, 1992), it seems likely that 
in some cell types they might also regulate the expression 
of genes involved in cell death. Indeed, there is already 
evidence that certain transcription factors, such as c-Myc 
and E2F, which were previously thought to be primarily 
involved in promoting cell proliferation, can also cause cell 
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death when overexpressed in serum-starved, quiescent 
fibroblasts (Evan et al., 1992; Wu and Levine, 1994; Qin 
et al., 1994). Furthermore, an association between the 
expression of a c-Fos-13-galactosidase fusion protein and 
certain forms of neuronal cell death has already been 
noted in c-fos-lacZ transgenic mice, but whether this was 
a cause or consequence of death was not determined 
(Smeyne et al., 1993). 
There are four members of the Foe family, c-Foe, Foe 
B, Fra 1, and Fra 2, and three members of the Jun family, 
c-Jun, Jun B, and Jun D, which bind as Jun/Jun or Jun/Fos 
dimers to the AP-1 binding site, or TPA response element 
(TRE; consensus sequence TGA C/G TCA) and which col- 
lectively constitute the activity known as AP-1 (Angel and 
Karin, 1991; Curran and Vogt, 1992). The transcription of 
the c-jun and c-foe genes is activated by a variety of signal 
transduction pathways, usually as an immediate arly re- 
sponse. In addition, the activity of the Jun and Foe proteins 
may be directly regulated by phosphorylation, proteolysis, 
or oxidation/reduction (Abate et al., 1990; Hirai et al., 1991 ; 
Karin, 1994; Treier et al., 1994). c-Jun and c-Foe activate 
transcription efficiently and can transform cells in culture. 
In contrast, the other members of the Jun family, Jun B 
and Jun D, are weaker transactivators and can antagonize 
c-Jun (Chiu et al., 1989; Hirai et al., 1989; SchStte et al., 
1989; Deng and Karin, 1993; Schlingensiepen et al., 1993; 
Pfarr et al., 1994). In the case of the Foe family, it has 
been suggested that Fra 1 and Fra 2 might function as 
negative regulators, since they are weak activators of tran- 
scription and cannot transform rodent fibroblasts (Wisdom 
and Verma, 1993). Changes in the relative levels of the 
different members of the AP-1 family can have important 
biological consequences (see, for example, Schlingensie- 
pen et al., 1993 and Pfarr et al., 1994), which emphasizes 
the importance of considering all of the family members 
when studying the role of AP-1 in a particular biological 
context. 
Here, we have used antibodies pecific for each mem- 
ber of the Jun and Foe family to investigate their pattern 
of expression in sympathetic neurons undergoing PCD. 
We find that the c-Jun protein is selectively induced in 
SCG neurons after NGF withdrawal, whereas the levels 
of the other members of the family do not change. The 
c-Jun protein also becomes more phosphorylated, proba- 
bly on its amino terminal transactivation domain, which 
normally increases the ability of c-Jun to activate the tran- 
scription of target genes. By using a c-Jun dominant nega- 
tive mutant, we demonstrate that AP-1 activity is essential 
for neuronal cell death. We also show that overexpression 
of c-Jun is in itself sufficient o trigger apoptosis in postmi- 
totic neurons. These results indicate that c-Jun plays a 
key role in the death of sympathetic neurons after NGF 
withdrawal. 
Results 
Selective Induct ion of c- Jun Protein during 
Neuronal  Cell Death 
To study the pattern of expression of the Jun and Foe 
family of transcription factors in rat SCG neurons undergo- 
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Figure 1. Pattern of Expression of the Jun and Fos Family of Proteins 
in NGF-Treated PC12 Cells 
Undifferentiated PC12 cells were treated with NGF, and whole-cell 
extracts were prepared at the times hown. Extracts were fractionated 
by SDS-PAGE on 10% gels and transferred to nitrocellulose; 15 pg 
of extract was loaded per lane. The various members of the AP-1 
family were detected by incubating the nitrocellulose filters with affinity- 
purified antibodies specific for each protein, as described in the Experi- 
mental Procedures. The identity of each rat Jun and Foe protein was 
verified by comparing its mobility with that of the corresponding mouse 
protein translated in vitro (data not shown). The brackets on the left 
indicate the bands corresponding to each protein. The position and 
size (in kilodaltons) ofmolecular weight markers that were run in paral- 
lel are shown on the right. 
ing apoptosis, we used a set of affinity-purified rabbit poly- 
clonal antibodies raised against the mouse Jun and Fos 
proteins (Pfarr et al., 1994). Each of these antibodies pe- 
cifically recognizes a single member of the AP-1 family 
and does not cross-react with the other Jun or Fos proteins 
(Pfarr et al., 1994; D. Lallemand, C. Pfarr, and M. Yaniv, 
unpublished data). To confirm that the antibodies recog- 
nized the appropriate rat proteins, we tested them in West- 
ern blots with extracts from undifferentiated PC12 cells 
treated with NGF for varying lengths of time. The pattern 
of expression of the Jun and Fos genes has been well 
characterized in this rat neuronal cell line, which responds 
to NGF by differentiating into cells with a phenotype similar 
to sympathetic neurons (Bartel et al., 1989; Schlingensie- 
pen et al., 1993; Gizang-Ginsberg and Ziff, 1994). As 
shown in Figure 1, each antibody recognized a PC12 pro- 
tein with a similar molecular weight to the mouse protein 
to which it was raised. NGF treatment led to a rapid but 
transient increase in the level of the c-Fos protein and to 
the appearance of forms with a lower mobility, previously 
reported to be the result of increased phosphorylation (see 
for example, Chen et al., 1993). The level of the Foe-related 
protein Fra 2 also increased after NGF treatment, but this 
increase was long lived rather than transient. The two 
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Figure 2. The c-Jun Protein Increases in Level and Becomes More 
Phosphorylated when SCG Neurons Are Deprived of NGF 
(A) SCG neurons were cultured for 7 days in the presence of NGF. Cells 
were then refed with medium lacking NGF,but containing anti-NGF 
antibody (-NGF) or with normal NGF-containing medium (+NGF). 
Whole-cell extracts were prepared at the times shown and fractionated 
on 10% SDS-polyacrylamide g ls; 7.5 ~.g of extract was loaded per 
lane. After transfer to nitrocellulose, the Fra 2, c-Jun, Jun B, and Jun 
D proteins were detected with affinity-purified antibodies as described 
in the Experimental Procedures. A nonspecific band recognized by 
the anti-c-Jun antibody in SCG extracts is marked with an asterisk. 
(B) Whole-cell extracts were prepared 0, 2, 4, or 8 hr after NGF had 
been withdrawn from 7-day-old cultures of SCG neurons (-NGF) or 
8 hr after the cells had been refed with NGF-containing medium 
(+NGF). The asterisk marks a nonspecific band detected by the anti-c- 
Jun antibody in SCG extracts. The brackets on the left indicate the 
bands that correspond to each protein. The position and size (in kilodal- 
tons) of molecular weight markers that were run inparallel are shown 
on the right. 
other members of the Fos family, Fos B and Fra 1, were 
not detected by our antibodies, which, however, did detect 
the mouse Fos B and Fra 1 proteins translated in vitro 
(data not shown). Fos B and Fra 1 may therefore be present 
at very low levels in PC12 cells, or it is possible that our 
antibodies do not recognize the rat Fos B and Fra 1 pro- 
teins. Like c-Fos, c-Jun was rapidly, but transiently, in- 
duced by NGF. Jun B was also induced by NGF but, in 
contrast o c-Jun, persisted at an increased level for days. 
Finally, as in the mouse system, the Jun D antibody recog- 
nized two bands that did not change in level after addition 
of NGF. In conclusion, each antibody appeared to recog- 
nize the rat homolog of the mouse protein for which it was 
specific, and the rat Jun and Fos proteins were induced 
by NGF with kinetics consistent with the published RNA 
data. 
Having checked the specificity of our antibodies, we 
then determined which members of the Jun and Fos family 
were expressed in rat primary SCG neurons and whether 
their levels of expression were altered by NG F withdrawal. 
SCG neurons were isolated from 1-day-old rats and cul- 
tured for 7 days in the presence of NGF and antimitotic 
agents. On day 7, cell death was induced by switching 
the neurons into medium without NGF but containing neu- 
tralizing anti-NGF antibody. At various times after NGF 
withdrawal, both adherent and detached apoptotic neu- 
rons were harvested, and total protein extracts were pre- 
pared. To control for any effects due to the addition of 
fresh serum or the disturbance caused by changing the 
growth medium, extracts were also prepared from cells 
that had simply been refed with medium containing NGF 
(Figure 2, +NG F control). The extracts were then fraction- 
ated by SDS-PAGE, and Western blots were carried out 
with the various Jun and Fos antibodies (Figure 2). 
Like differentiated PC12 cells (see Figure 1, 7d), SCG 
neurons expressed Fra 2, c-Jun, Jun B, and Jun D, but 
not c-Fos. Fos B and Fra 1 were also not detected. After 
NGF withdrawal, the levels of Fra 2, Jun B, and Jun D 
remained more or less constant. Furthermore, there was 
no increase in the levels of the Fra 2, Jun B, or Jun D 
proteins at timepoints earlier than 8 hr after NGF with- 
drawal (Figure 2B; data not shown). In contrast o the other 
members of the AP-1 family, the overall level of c-Jun pro- 
tein increased significantly after NGF withdrawal, and 
there was also a dramatic change in its mobility. A more 
detailed analysis (Figure 2B) showed that the change in 
c-Jun mobility appeared to begin about 4 hr after NGF 
withdrawal. Again, alterations in the level and mobility of 
c-Jun protein were not seen in the +NGF control, indicat- 
ing that these changes were the result of NGF withdrawal 
and were not due to the addition of fresh medium. Finally, 
c-Fos protein was not detected by Western blotting at 2, 
4, 8, 16, or 24 hr after NGF withdrawal (data not shown), 
even though it could be readily detected in similar extracts 
from NGF-treated PC12 cells (see Figure 1). In conclusion, 
c-Jun was the only one of the AP-1 proteins examined that 
was significantly affected by NGF withdrawal. 
Although inclusion of a preplating step and addition of 
anti-mitotic agents to the growth medium (see Experimen- 
tal Procedures) kept the percentage of nonneuronal cells 
in our SCG cultures very low, it was still formally possible 
that the c-Jun protein detected in Western blots might be 
derived from contaminating Schwann cells or fibroblasts. 
To rule out this possibility, we carried out'immunofluores- 
cence experiments with the anti-c-Jun antibody (Figure 
3). The c-Jun antibody weakly stained the cytoplasm and 
nuclei of SCG neurons maintained in the presence of NGF 
(Figure 3A) However, after NGF withdrawal, nuclear stain- 
ing increased dramatically (Figure 3C). This increased nu- 
clear staining first appeared at the same time that c-Jun 
protein levels started to increase in Western blots (data 
not shown). At the timepoint shown in Figure 3C (24 hr 
after NGF withdrawal), both normal and pyknotic nuclei 
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Figure3. Immunofluorescence Analysis of 
c-Jun and c-Fos Expression in SCG Neurons 
(A) SCG neurons were cultured for 7 days in 
the presence of NGF and then fixed and 
stained with the anti-c-Jun antibody. In the 
presence of NGF, weak staining of the cell body 
and nucleus was observed with the anti-c-Jun 
antibody. 
(B) The cells shown in (A) stained with Hoechst. 
(C) SCG neurons (7 days old) were withdrawn 
from NGF for 24 hr and then stained with e 
anti-c-Jun antibody. Both normal and pyknotic 
nuclei with condensed chromatin stained 
brightly for c-Jun. 
(D) The cells shown in (C) stained with Hoechst. 
(E) SCG neurons were deprived of NGF for 24 
hr and then stained with the anti-c-Fos anti- 
body. At this timepoint, less than 1% of the 
cells expressed c-Fos protein. Those that did 
expressed high levels of c-Fos and had slightly 
deformed nuclei. A typical example is shown. 
(F) The cells shown in (E) stained with Hoechst. 
Immunofluorescence was carried out as de- 
scribed in the Experimental Procedures ec- 
tion. The neurons were plated on glass cov- 
erslips coated with poly-L-lysine and laminin at 
a density of 8000 cells per covemlip. Bar, 25 p.m. 
l 
were stained, indicating that c-Jun protein levels increased 
before there were any visible changes in nuclear morphol- 
ogy, and that c-Jun protein was present in cells undergoing 
apoptosis. 
Although we could not detect c-Fos in dying SCG neu- 
rons by Western blotting, we also investigated its pattern 
of expression by immunofluorescence, since it had pre- 
viously been reported that expression of a c-Fos-13- 
galactosidase fusion protein was associated with neuronal 
cell death in c-fos-lacZ transgenic mice (Smeyne et al., 
1993). The immunofluorescence results for c-Fos were 
different from those obtained for c-Jun (Figures 3E and 
3F). NGF withdrawal led to the induction of c-Fos in SCG 
neurons, but at later timepoints only and in only a tiny 
percentage of the cells. For example, at 24 hr after NGF 
withdrawal, less than 1% of the cells expressed c-Fos 
protein (Figure 3E). This could explain why we did not 
detect c-Fos in Western blots. Furthermore, the Fos- 
expressing cells always had deformed nuclei, usually in 
the early stages of becoming pyknotic (compare Figures 
3E and 3F). This suggests that, in contrast o c-Jun, c-Fos 
is only induced after a cell has become committed to die 
and at the same time as, or after, the first changes in 
nuclear morphology have begun. 
A Dominant Negative c-Jun Mutant Blocks 
Neuronal Cell Death 
Our Western blotting and immunofluorescence xperi- 
ments demonstrated that the c-Jun protein was selectively 
induced when $CG neurons were deprived of NGF. To 
determine the role of c-Jun during neuronal cell death, we 
tested the effect of interfering with c-Jun function in SCG 
neurons by microinjecting an expression vector encoding 
a dominant negative c-Jun mutant, FLAGA169 (Figure 
4A). The c-Jun deletion mutant A169 was derived from 
the mouse c-Jun cDNA by deleting sequences that encode 
the amino terminal c-Jun transactivation domain (amino 
acids 1-168). Although c-Jun A169 cannot activate tran- 
scription, it can still efficiently dimerize and bind to DNA 
(Hirai et al., 1989) and acts as a dominant negative mutant 
(Castellazzi et al., 1991). A169 will prevent any member 
of the Jun and Fos family from activating transcription of 
AP-l-dependent target genes and may do so by occupying 
AP-1 binding sites in the place of functional Jun/Jun or 
Jun/Fos dimers (see Brown et al., 1994, for a discussion 
of the mechanism of inhibition). We added the 8 amino 
acid FLAG epitope to the amino terminus of A169 so that 
we could monitor its expression in microinjected neurons 
by immunofluorescence with the M2 monoclonal antibody 
and thereby distinguish it from the endogenous c-Jun pro- 
tein. The DNA sequences encoding FLAGA169 were 
cloned into pCDNA1 under the control of the powerful cyto- 
megalovirus (CMV) immediate early promoter, which 
drives high level expression in a wide variety of cell types 
(Boshart et al., 1985). 
To verify that FLAGA169 was efficiently expressed and 
correctly localized in injected neurons, we microinjected 
pCDFLAGA169 together with purified guinea pig IgG (to 
mark the injected cells). At 24 hr after injection, the cells 
were fixed and stained with antibodies against guinea pig 
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Figure 4. Structure, Pattern of Expression, and Activity of the c-Jun 
Dominant Negative Mutant FLAGA169 
(A) Diagram showing the structure of FLAGA169 and the AP-1 reporter 
gene TRElacZ. The mouse c-Jun open reading frame is shown at the 
top. The amino-terminal transactivation domain is shaded. Plus signs 
represent he basic region that contacts DNA; L, the leucine zipper 
dimerization domain. FLAGA169 starts at amino acid residue 169 and 
therefore lacks the transactivation domain but contains the basic/ 
leucine zipper egion. The 8 amino acid FLAG epitope added to the 
amino terminus is represented by a closed box. The construction of 
FLAGA169 is described in the Experimental Procedures. TRElacZ 
contains four copies of the collagenase gene TRE cloned upstream 
of a Rous sarcoma virus minimal promoter linked to the E. coli 
P-galactosidase gene. 
(B) FLAG A 169 is efficiently expressed in microinjected SCG neurons 
and correctly localizes to the nucleus. SCG neurons were microin- 
jected with pCDFLAGA169 at 0.05 mg/ml and guinea pig IgG at 5 mg/ 
ml. At 24 hr after injection, the cells were fixed and stained with a 
rhodamine-conjugated anti-guinea pig IgG antibody (Jeff) to detect he 
injected neurons and the M2 monoclonal antibody (right) to detect the 
FLAG epitope. The M2 monoclonal antibody was detected with an 
fluorescein isothiocyanate-conjugated anti-mouse IgG antibody. At 
IgG and the M2 monoclonal antibody (Figure 4B). A group 
of representative injected cells are shown (Figure 4B, left), 
all of which expressed FLAGA169 (Figure 4B, right). In 
general, FLAGA169 was expressed in 95% of the cells 
that survived injection and was always localized to the 
nucleus. To confirm that FLAGA 169 inhibited AP-1 activity 
in SCG neurons, we injected an AP-1 reporter gene, TREI- 
acZ, together with either the empty pCDNA1 expression 
vector or pCDFLAGA169. TRElacZ contains four AP-1 
binding sites (TREs) cloned upstream of a Rous sarcoma 
virus minimal promoter l inked to the Escherichia coli 13- 
galactosidase gene (Figure 4A; Alberts et al., 1993), After 
injection, the neurons were switched into medium without 
NGF for 24 hr and then were fixed and stained with an 
anti-15-galactosidase antibody. The number of cells ex- 
pressing P-galactosidase was determined, and the result 
is shown in Figure 4C. Expression of FLAGA169 reduced 
the percentage of 13-galactosidase-positive c lls by 3-fold 
relative to the population injected with pCDNA1, indicating 
that it does indeed act as a dominant inhibitor of AP-1 
activity in dying SCG neurons. 
We next investigated whether the expression of FLAG 
A169 in SCG neurons could prevent or slow cell death 
after NGF withdrawal. In these experiments we com- 
pared the c-Jun dominant negative mutant with pCDNA1, 
which should not alter the time course of death, and with 
pCDbcl-2, a Bcl-2 expression vector. The latter served as 
a positive control, since overexpression of Bcl-2 has pre- 
viously been shown to slow the rate of death of sympa- 
thetic neurons deprived of NGF (Garcia et al., 1992). The 
expression vectors were injected into 4- to 5-day-old SCG 
neurons together with Texas Red dextran to mark the in- 
jected cells. After injection, the cells were left overnight 
to al low time for the injected DNAs to be expressed and 
then were refed with medium lacking NGF and containing 
anti-NGF antibody. Immediately after the medium change, 
the number of Texas Red-posit ive cells was determined. 
The cells were deprived of NGF for 2 or 3 days, and calcein 
AM was then added to the medium to mark viable cells. 
The percentage of viable cells at 2 or 3 days after NGF 
withdrawal was then calculated as described in the Experi- 
mental Procedures section. The outcome of these experi- 
ments is shown in Figure 5. After NGFwithdrawal ,  neurons 
injected with pCDbcl-2 showed increased survival com- 
pared with those injected with the empty expression vector 
pCDNA1 or with Texas Red dextran alone, a result consis- 
left, 7 injected cells are shown. Differences in the staining intensity 
are the result of differences in the volume of solution injected. Guinea 
pig IgG present in the cytoplasm of 2 cells was the result of spill- 
over during injection of the nucleus. All 7 injected cells expressed 
FLAGA169, which localized to the nucleus (right). Bar, 25 p.m. 
(C) FLAGA169 inhibits AP1 activity in SCG neurons. AP-1 activity 
was measured by injecting TRElacZ into SCG neurons. TRElacZ was 
injected at 0.2 mg/ml together with either pCDNA1 (as a negative 
control) or pCDFLAGA169 also at 0.2 mg/ml. The injected cells were 
deprived of NGF for 24 hr and then were fixed and stained with an 
antibody against p-galactosidase as described in the Experimental 
Procedures. The results are the mean - SEM for 4 independent exper- 
iments. In each experiment, 200 neurons were injected with each injec- 
tion mix. 
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Figure 5. The c-Jun Dominant Negative Mutant FLAGA169 and Bcl-2 
Each Protect Sympathetic Neurons against Cell Death after NGF With- 
drawal 
SCG neurons (4-5 days old) were injected with pCDFLAGA169 or 
pCDbcl-2 or pCDNA1 at 0.05 mg/ml together with Texas Red dextran 
at 20 mg/ml (to mark the injected cells). Several hours later, the injected 
cells were refed with medium lacking NGF, but containing anti-NGF 
antibody. Immediately after refeeding, the number of neurons that had 
survived injection was determined. At 2-3 days later, the percentage 
of viable, injected neurons that remained was determined by staining 
with calcein AM, as described in the Experimental Procedures section. 
Each point represents the mean __+. SEM for three independent experi- 
ments. In each experiment, 200 neurons were injected with each con- 
struct. Open circles, pCDFLAGA169; open squares, pCDbcl-2; closed 
circles, pCDNA1; closed squares, Texas Red dextran alone. 
tent with the findings of Garcia et al. (1992). Importantly, 
injection of pCDFLAGA169 also led to a higher percentage 
of surviving cells. In fact, FLAGA169 was as effective as 
Bcl-2 in protecting the injected neurons from PCD. Further- 
more, the viable neurons expressing FLAGA169 had a 
similar morphology to those saved by Bcl-2 (data not 
shown). This result indicates that AP-1 activity is rate lim- 
iting for neuronal cell death after NGF withdrawal, since 
death can be inhibited by overexpressing a c-Jun domi- 
nant negative protein. Since c-Jun is the only member of 
the Jun and Fos family that significantly increases in level 
after SCG neurons are deprived of NGF, it is likely that 
c-Jun is an important component of the form of AP-1 es- 
sential for the resulting cell death. 
Having demonstrated that c-Jun protein levels increase 
after NGF withdrawal and that AP-1 activity is essential 
for this form of cell death, we wondered whether overex- 
pression of c-Jun alone is sufficient to cause the death 
of SCG neurons. We therefore injected neurons with an 
expression vector for the full-length c-Jun protein (pCDc- 
Jun) or with a ~-galactosidase xpression vector (CMVlacZ) 
as a negative control. After injection, the neurons were 
maintained in the presence of NGF for 4 days and then 
were fixed and stained with the anti-c-Jun antibody or with 
a monoclonal ant ibody against 13-galactosidase to detect 
cells overexpressing c-Jun or 15-galactosidase, respec- 
tively. Nuclear morphology was visualized by Hoechst 
staining, and the percentage of pyknotic nuclei was deter- 
mined for cells expressing c-Jun or I~-galactosidase. At 4 
days after injection, 10% of the uninjected cells had pyk- 
notic nuclei (Figure 6A). When CMVlacZ was injected at 
A 
% pyknotic 
nuclei 
B 
10O - 
90: 
80- 
70~ 
60- 
50 
40  
30~ 
20~ 
104 
O: 
pCDc-Jun 
CMVlacZ 
0.05 011 0.15 012 
Concentration of injected DNA (mg / rnl) 
anti - IgG anti - c-Jun Hoechst 
Figure 6. Overexpression of c-Jun Alone Is Sufficient to Induce 
Apoptosis in SCG Neurons 
(A) SCG neurons that had been cultured in the presence of NGF for 
7 days were injected with pCDc-Jun or CMVlacZ at 0.05 or 0.2 mg/ 
ml together with guinea pig IgG at 5 mg/ml (to mark the injected cells). 
After injection, the cells were refed with NGF-containing medium and 
left for 4 days. The neurons were then fixed and stained with an anti- 
body against guinea pig I G and antibodies against c-Jun or I~-galac- 
tosidase. Nuclear morphology was visualized by Hoechst staining. The 
percentage of pyknotic nuclei was then determined for cells overex- 
pressing c-Jun or ~-galactosidase and for uninjected cells. Only nuclei 
that were unequivocally pyknotic (i.e., those with highly condensed 
chromatin or that were grossly distorted or fragmented) were scored 
as pyknotic. For injections at 0.05 mg/ml, the results shown are the 
mean of 3 independent experiments _+ SEM. For injections at 0,2 rag/ 
ml, the results are the mean of 5 independent experiments. Closed 
circles, pCDc-Jun; open circles, CMVlacZ. 
(B) Morphology of injected neurons overexpressing c-Jun. Two repre- 
sentative cells are shown. The injected cells were marked by including 
guinea pig IgG in the injection mix (left). Hoechst staining (right) shows 
that one has a normal nucleus, as can be seen by comparing it with 
the uninjectecl cells nearby. The other c-Jun-expressing cell has a 
shrunken, crescent-shaped nucleus with condensed chromatin. Bar, 
17 ~m. 
a concentration of 0.05 mg/ml, 12% of the cells expressing 
13-galactosidase had pyknotic nuclei. In contrast, 43% of 
the cells injected with pCDc- Jun at an equivalent concen- 
tration were pyknotic, a 3.5-fold increase over the back- 
ground level in cells injected with the CMVlacZ control 
vector. When CMVlacZ was injected at a higher concentra- 
tion (0.2 mg/ml), 33% of the cells had pyknotic nuclei, a 
3-fold increase compared with the uninjected cells. This 
was presumably a nonspecific effect due to expression of 
high levels of I~-galactosidase or the presence of the strong 
CMV promoter. Importantly, however, 73% of the cells 
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Figure 7. Overexpression of Bcl-2 Does Not Prevent Induction of 
c-Jun after NGF Withdrawal 
SCG neurons were injected with pCDbcl-2 or CMVlacZ at 0.05 mg/ml 
and were then refed with medium lacking NGF but containing anti-NGF 
antibody. At 24 hr later, the cells were fixed and stained with antibodies 
against Bcl-2 or 13-galactosidase and the anti-c-Jun antibody. The per- 
centage of neurons expressing Bcl-2 or .B-galactosidase that also ex- 
pressed c-Jun was then determined. Only those cells in which c-Jun 
staining was clearly above background were scored as c-Jun positive. 
The results hown are the mean of 3 independent experiments -+ 
SEM. In each experiment, 200 neurons were injected with each con- 
struct. 
injected with pCDc-Jun at 0.2 mg/ml were pyknotic, a 
2.2-fold increase over the background level in cells in- 
jected with CMVlacZ (Figure 6A). The morphology of two 
representative cells overexpressing c-Jun is shown in Fig- 
ure 6B. The injected cells were marked by including guinea 
pig IgG in the injection mix (Figure 6B, left); c-Jun staining 
is shown in the center panel. Hoechst staining (Figure 6B, 
right) shows that one cell has a normal nucleus, as can 
be seen by comparing it with the uninjected cells nearby. 
The other c-Jun-expressing cell has a shrunken, crescent- 
shaped nucleus with condensed chromatin. In general, 
the level of c-Jun expressed in cells injected with pCDc- 
Jun was similar to, or higher than, that observed in SCG 
neurons after NG F withdrawal (data not shown). In conclu- 
sion, these results indicate that as well as c-Jun being 
essential for neuronal cell death, overexpression of c-Jun 
is in itself sufficient o trigger apoptosis in SCG neurons 
and can override the protective effect of NGF. 
Finally, we wondered whether Bcl-2 might protect SCG 
neurons against PCD by blocking induction of c-Jun. We 
therefore injected neurons with pCDbcl-2 or, as a negative 
control, with CMVlacZ. After injection, the neurons were 
withdrawn from NGF for 24 hr and then were fixed and 
stained with monoclonal antibodies against Bcl-2 or 13-ga- 
lactosidase and the anti-c-Jun polyclonal antibody. The 
results of this experiment are shown in Figure 7. At 24 hr 
after removal of NGF, 50% of the uninjected cells ex- 
pressed c-Jun. When cells were injected with CMVlacZ, 
this figure was slightly reduced. In the case of neurons 
injected with pCDbcl-2, there was no reduction in the per- 
centage of cells expressing c-Jun protein, demonstrating 
that Bcl-2 does not promote the survival of NGF-deprived 
SCG neurons by inhibiting induction of c-Jun. 
Discussion 
We have used antibodies pecific for each member of the 
Jun and Fos family of transcription factors to study their 
pattern of expression in sympathetic neurons undergoing 
PCD. We found that sympathetic neurons express Fra 2, 
c-Jun, Jun B, and Jun D. However, after NGF withdrawal, 
c-Jun was the only one of these proteins whose pattern 
of expression changed significantly. Two effects were evi- 
dent; first, c-Jun protein levels increased substantially, 
whereas the levels of Fra 2, Jun B, and Jun D remained 
relatively constant; second, the mobility of the c-Jun pro- 
tein changed, starting about 4 hr after NGF withdrawal. 
Although we could not detect c-Fos in dying SCG neurons 
by Western blotting, we found in immunofluorescence ex- 
periments that at late time points after NGF withdrawal, 
a few cells (less than 1% at 24 hr) expressed high levels 
of c-Fos protein. These cells always had pyknotic nuclei, 
suggesting that induction of c-Foe occurred at the same 
time as, or after, the first changes in nuclear morphology 
had taken place. Our results are therefore consistent with 
those of Smeyne et al. (1993), who observed that c-Fos 
expression is associated with certain forms of neuronal 
cell death in vivo. However, in the neurons we have stud- 
ied, c-Foe induction appears to be a relatively late event, 
which either occurs transiently in all dying neurons, or 
which only occurs in a subset of dying neurons. In contrast, 
we detected c-Jun protein in both normal and pyknotic 
nuclei, and it appeared to be induced much earlier than 
c-Fos. Since 50% of SCG neurons are committed to die 
by 22 hr after NGF withdrawal (Deckwerth and Johnson, 
1993), it seems that c-Jun is induced before, and c-Fos 
after, a neuron has become committed to die. 
The increase in c-Jun protein levels that we have ob- 
served might be the result of increased transcription of 
the c-jun gene. The c-Jun protein positively autoregulates 
its own expression and is permanently bound to two vari- 
ant TRE sequences in the c-jun promoter as c-Jun/activat- 
ing transcription factor 2 heterodimers, whose activity is 
regulated by phosphorylation (Angel et al., 1988; Herr et 
al., 1994). Stimuli, such as ultraviolet treatment, that in- 
crease the rate of transcription of the c-jun gene do so by 
activating protein kinases that phosphorylate the c-Jun 
transcriptional activation domain on serines 63 and 73. 
This has been shown to increase the ability of c-Jun to 
activate the transcription of target genes, including the 
c-jun gene itself (Pulverer et al., 1991 ; Smeal et al., 1991, 
1992; Karin, 1994). Interestingly, we observed that when 
SCG neurons undergo apoptosis, the apparent mobility 
of the c-Jun protein in SDS-PAGE decreases. Previously, 
this change was found to correlate with increased phos- 
phorylation of the c-Jun transcriptional activation domain 
on serines 63 and 73 (Pulverer et al., 1991; Kyriakis et 
al., 1994). A family of Jun amino terminal kinases, also 
known as stress-activated protein kinases, which directly 
bind and phosphorylate the c-Jun transactivation domain, 
has recently been identified, and several members have 
now been cloned (Hibi et al., 1993; D~rijard et al., 1994; 
Kyriakis et al., 1994). Although related to MAP kinases, 
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the Jun kinases preferentially phosphorylate c-Jun and are 
activated by different stimuli, notably ultraviolet radiation, 
tumor necrosis factor a, ceramide, cellular stress, and re- 
active oxygen species (Davis, 1994), all treatments that 
can cause cell death. It is tempting to speculate that NGF 
withdrawal eads to some form of cellular stress, perhaps 
an increase in reactive oxygen species, which causes the 
activation of Jun kinase. Thus, the change in the mobility 
of c-Jun that we have observed would be consistent with 
phosphorylation by a member of the Jun kinase family, 
starting about 4 hr after NGF withdrawal. Activation of 
c-Jun by phosphorylation would lead to activation of the 
c-jun promoter, which might account for the increase in 
c-Jun protein levels that we have observed. 
What might be the role of the c-Jun protein induced in 
dying SCG neurons? There are several possibilities. For 
example, c-Jun might cause cell death by activating the 
transcription of target genes whose protein products are 
either effectors or triggers of the cell death program. Alter- 
natively, c-Jun activation might be the result of certain 
physiological changes that occur after NGF withdrawal, 
and c-Jun might activate genes that encode proteins that 
counteract hese physiological changes; i.e., c-Jun might 
orchestrate a protective or homeostatic response. Finally, 
a number of studies have reported a delayed and pro- 
longed induction of c-Jun in peripheral sensory neurons 
or motor neurons after axon damage. Since c-Jun re- 
mained at elevated levels until the nerve had fully regener- 
ated, it was suggested that in this context c-Jun might be 
involved in regeneration (see, for example, Gold et al., 
1993 and De Felipe and Hunt, 1994). To distinguish among 
these different possibilities, we tested the effect of overex- 
pressing a transactivation-defective c-Jun dominant nega- 
tive mutant in SCG neurons. We found that this mutant 
blocked AP-1 activity in SCG neurons (see Figure 4) and 
protected them against PCD as effectively as Bcl-2 did 
(see Figure 5). Even though FLAGA169 does not distin- 
guish among different members of the Jun and Fos family, 
we can safely conclude that AP-1 activity is essential for 
the death of SCG neurons after NGF withdrawal. However, 
we believe that c-Jun plays a key role because, first, it is 
the only member of the family whose level significantly 
increases after NGF withdrawal; second, it is induced in 
all of the SCG neurons before they are irreversibly commit- 
ted to cell death; and, third, its overexpression is sufficient 
to induce apoptosis in SCG neurons. How might c-Jun 
function in this situation? One possibilty is that it forms 
heterodimers with Fra 2, which is expressed in sympa- 
thetic neurons, or with other proteins, such as activating 
transcription factor 2. Alternatively, as has previously been 
demonstrated, c-Jun might act on its own as a homodimer. 
Our results do not exclude the possiblility that c-Jun might 
also be involved in regeneration in vivo, especially since 
our experiments were carried out with purified cultures of 
neurons isolated from their normal environment. Indeed, 
c-Jun might simultaneously activate genes that cause cell 
death and genes involved in regeneration, the outcome 
perhaps being determined by interactions with other neu- 
rons or glial cells. 
While this manuscript was in preparation, Estus et al. 
(1994) reported similar results in sympathetic neurons. Us- 
ing the technique of reverse transcription-PCR (RT-PCR), 
these authors found that the c-Jun, c-Fos, and Fos B 
mRNAs increased in level after NGF withdrawal, and that 
microinjection of an anti-c-Jun antibody inhibited cell 
death. Our findings, which were obtained by a different 
approach, confirm and extend their results. In contrast to 
Estus et al., we used antibodies specific for each member 
of the Jun and Fos family to study their pattern of expres- 
sion in SCG neurons. In Western blotting and immunofluo- 
rescence experiments, we have demonstrated that the 
changes in RNA level detected by Estus et al. actually 
lead to changes in protein level. Furthermore, we have 
also been able to detect a posttranslational modification 
of the c-Jun protein, which suggests that a signal transduc- 
tion pathway that activates Jun kinase may play a role in 
neuronal cell death. Estus et al. found that the level of 
c-Jun RNA increases about 5 hr after NGF withdrawal, 
which is also the time at which we first observed increased 
phosphorylation of c-Jun. These results are entirely con- 
sistent with a model in which increased phosphorylation 
of c-Jun by a member of the Jun kinase family leads to 
transcriptional activation of the c-jun promoter. Estus et 
al. also demonstrated by RT-PCR that the c-Fos mRNA 
increases in level after NGF withdrawal. In contrast, we 
were unable to detect c-Fos protein in dying SCG neurons 
by Western blotting, although our antibody readily de- 
tected c-Fos when it was present, for example, in NGF- 
treated PC12 cells (see Figure 1). We did, however, find 
a small number of Fos-expressing cells when we used 
the same antibody in immunofluorescence. These results 
suggest that although the c-Fos RNA could be detected 
by the extremely sensitive technique of RT-PCR, relatively 
few dying SCG neurons actually expressed detectable 
c-Fos protein. By injecting antibodies against various 
members of the AP-1 family, Estus et al. demonstrated 
that c-Jun and members of the Fos family are essential for 
cell death. Our observation that a transactivation-defective 
c-Jun dominant negative mutant blocks the death of SCG 
neurons is consistent with their results and, in addition, 
demonstrates that c-Jun and its partners from the Fos 
family cause cell death by binding to DNA and activating 
transcription. We strengthen this argument by showing 
that overexpression of c-Jun alone can trigger cell death 
in neurons. Finally, Estus et al. speculated that induction 
of c-Jun might be the result of oxidative stress after NGF 
withdrawal. Since it has been suggested that Bcl-2 may 
block oxidative damage (Hockenbery et al., 1993), they 
proposed that Bcl-2 might prevent neuronal cell death by 
inhibiting induction of c-Jun. However, we have found that 
this is not the case. By injecting neurons with a Bcl-2 ex- 
pression vector and carrying out immunofluorescence 
with an anti-c-Jun antibody, we found that NGF withdrawal 
led to c-Jun induction, even when Bcl-2 was overex- 
pressed (see Figure 7). We propose that Bcl-2 acts down- 
stream of c-Jun, perhaps by inactivating cytosolic cell 
death effector proteins. This would be consistent with the 
observations of Jacobson et al. (1994), who found that 
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Bcl-2 expression can protect cytoplasts against cell death 
induced by survival factor withdrawal or by treatment with 
the broad spectrum kinase inhibitor staurosporine. 
Our results provide a further example of the usefulness 
of c-Jun dominant negative mutants for investigating the 
biological functions of members of the Jun and Fos family. 
Mutants similar to FLAGA169 have been used to show 
that AP-1 activity is important for cell proliferation (Cas- 
tellazzi et al., 1991), necessary for Ras to transform fi- 
broblasts (Lloyd et al., 1991), and that Drosophila Jun 
mediates Ras-dependent photoreceptor determination 
(Bohmann et al., 1994). Identification of genes that are 
essential for mammalian cell death has been hampered 
by the lack of a suitable genetic system. However, the 
microinjection of neurons with vectors that express natu- 
rally occurring inhibitors such as crmA, a viral inhibitor of 
interleukin ll.~-converting enzyme (ICE) family proteases, 
has provided an alternative approach (Gagliardini et al., 
1994). The use of dominant negative mutants such as the 
c-Jun dominant negative described in this paper repre- 
sents another strategy that could be used in the future for 
studying the role of other transcription factors in neuronal 
cell death or to dissect the signal transduction pathway 
that leads to the induction of c-Jun in dying sympathetic 
neurons. It would also be interesting to study the role of 
c-Jun in neuronal cell death in vivo. Although the mouse 
c-jun gene has been disrupted by homologous recombina- 
tion, the resulting c-jun (-I-) mice had a complex phenotype 
and died during embryonic development at about 12.5 
days (Johnson et al., 1993; Hilberg et al., 1993), thus 
precluding an analysis of the role of c-jun in the develop- 
mental death of sympathetic neurons, which occurs after 
birth. However, the creation of transgenic mice in which 
FLAGA169 is expressed under the control of a promoter 
specific for postmitotic neurons, such as that of the neu- 
ron-specific enolase gene (Forss-Petter et al., 1990), 
would provide an alternative approach. It would also en- 
able us to address the question of whether AP-1 activity 
is necessary for neuronal regeneration in vivo. 
Our results demonstrate that c-Jun is essential for the 
PCD of sympathetic neurons. What role might c-Jun play 
during this process? A simple hypothesis would be that, 
following NGF withdrawal, c-Jun might activate the tran- 
scription of genes encoding proteins essential for cell 
death, such as members of the CED-3/ICE family of prote- 
ases. Before NGF withdrawal, such proteins might be 
present at limiting concentrations, and an increase in their 
levels might override the protective effect of cell death 
suppressors such as the Bcl-2 protein. Consistent with 
such a model, artificially increasing the concentration of 
ICE in DRG neurons by overexpression was found to 
cause apoptosis (Gagliardini et al., 1994). Furthermore, 
apoptosis of mammary epithelial cells induced by loss of 
contact with the extracellular matrix was found to be asso- 
ciated with an increase in the level of ICE RNA and re- 
quired the activity of ICE family proteases (Boudreau et 
al., 1995). Arguments against a model in which genes en- 
coding cell death effectors are activated during cell death 
have been presented by Jacobson et al. (1994) and were 
based on the observation that cells can undergo apoptosis 
in the absence of a nucleus. These authors concluded 
that the cell death effector proteins must be cytosolic, pre- 
exist in all cells, and can be activated posttranslationally. 
Though this is certainly true in those situations in which 
cell death does not require new transcription or protein 
synthesis, it does not exclude the possibility that in other 
situations the cell death machinery may be activated by 
increasing the level of cell death effectors through new 
synthesis. 
An alternative hypothesis, which we favor, is that c-Jun 
might be essential for cell death because it activates genes 
involved in cell proliferation. We have previously hypothe- 
sized that the cell death that follows the withdrawal of NGF 
from postmitotic neurons may be the result of an abortive 
attempt o reenter the cell cycle (Rubin et al., 1993, 1994). 
According to this model, removal of NGF would lead to 
the activation of cyclin-dependent kinases or other pro- 
teins that drive cell cycle progression. In the context of a 
terminally differentiated neuron that has withdrawn from 
the cell cycle, such enzymes might function directly as 
cell death effector proteins; i.e., components of the cell 
cycle machinery would be employed in the cell death pro- 
gram. Alternatively, the inappropriate activation of such 
enzymes in postmitotic neurons might trigger the cell 
death program. Evidence to support this type of idea has 
come from a recent study by Freeman et al. (1994). These 
authors used RT-PCR analysis to investigate whether cell 
cycle genes are expressed in sympathetic neurons and 
to determine whether any of these are induced by NGF 
withdrawal. Though the level of most of the transcripts 
they studied decreased in dying neurons, the cyclin D1 
mRNA was selectively induced, peaking at 15-20 hr after 
NGF withdrawal, the time when neurons become commit- 
ted to die. However, it was not demonstrated whether 
cyclin D1 was essential for cell death or whether a cyclin 
Dl-dependent kinase was activated. Interestingly, the 
cyclin D 1 gene is a potential target of c-Jun transactivation, 
since the cyclin D1 promoter contains potential AP-1 bind- 
ing sites and can be activated by overexpression of c-Jun 
in transient ransfection experiments (Herber et al., 1994). 
Consistent with such an idea, c-Jun protein levels start to 
increase 4-8 hr after NGF withdrawal (see Figure 2) before 
cyclin D1 levels peak (15-20 hr). Freeman et al. also 
showed that SCG neurons do not express CDK2, cyclin 
A, or CDC2, all of which are required for normal cell cycle 
progression. Therefore the transcriptional ctivation of proto- 
oncogenes, such as c-Jun and cyclin D1, which would 
act as a strong growth-promoting signal, in cells that are 
locked out of the cell cycle might be the event that triggers 
apoptosis. 
In conclusion, we have demonstrated that the c-Jun pro- 
tein is selectively induced in sympathetic neurons under- 
going PCD, and by microinjecting a dominant negative 
c-Jun expression vector we have shown that AP-1 activity 
is essential for this form of cell death. Future experiments 
will be directed toward identifying Jun target genes and 
toward determining the mechanisms that are responsible 
for the increase in the level of c-Jun protein and for its 
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increased phosphorylat ion.  Our  results also show that, in 
addit ion to playing an important  role in cell prol i feration 
and differentiat ion, c-Jun may also be involved in cell 
death.  Future work  will determine whether  this is true for 
other  kinds of neurons and cell types. 
Experimental Procedures 
Cell Culture 
Sympathetic neurons from the superior cervical ganglia of 1-day-old 
Sprague-Dawley rats were isolated and cultured as described by John- 
son and Argiro (1983) with certain modifications. In brief, after dissec- 
tion, the ganglia were desheathed in L15 medium plus 0.1% fetal calf 
serum plus penicillin/streptomycin a d then dissociated by treatment 
with a 1:1 mixture of 0.4% collagenase/trypsin-EDTA and by triturao 
tion, using a syringe and 19G and 23G needles. Nonneuronal cells 
were then removed by plating the cell suspension in 10 ml of growth 
medium (for up to 30 ganglia) in an uncoated 9 cm dish for 2.5 hr. 
The resulting supernatant enriched in SCG neurons was then plated 
on 3.5 cm diameter dishes coated with poly-L-lysine and collagen in 
DMEM containing 10% fetal calf serum, 2 mM glutamine, penicillin/ 
streptomycin, and NGF at 50 ng/ml. Collagen was prepared from fresh 
rat tails. NGF (2.5 S) was provided by S. Brooks and purified from 
adult male mouse submaxillary glands as described (Suda et al., 1978). 
The antimitotic agents fluorodeoxyuridine and uridine were added to 
a final concentration of 20 p.M to limit the proliferation of nonneuronal 
cells. The neurons were usually maintained for 6-8 days in the pres- 
ence of NGF before being used for cell death experiments. NGF with- 
drawal was carried out by changing the medium to DMEM/10% fetal 
calf serum lacking NGF and containing anti-NGF antibodyat 100 ng/ml 
(Boehringer Mannheim). For immunofluorescence and microinjection 
experiments, neurons were plated on glass coverslips coated with 
poly-L-lysine and laminin. PC12 cells were cultured in SATO medium 
as described by Doherty et al. (1988) at a density of 2 x 106 cells per 
dish in 9 cm dishes coated with poly-L-lysine and collagen. 
Western Blot and Immunofiuorescence Analysis 
Ceil extracts for Western blotting were prepared as follows. The growth 
medium from the neuronal cultures was removed but kept, so that 
any detached, apoptotic cells would be included in the analysis. The 
attached neurons that remained were then harvested by scraping in 
a small volume of ice cold PBS. Adha rent and floating cells were pooled 
and pelleted by centrifugation at 2000 rpm for 5 rain at 4°C in a bench 
centrifuge. The cell pellet was resuspended in 1 ml of ice cold PBS 
and transferred to a microfuge tube. The cells were then repelleted 
and resuspended in 50-200 p,I of SDS lysis buffer (10 mM Tris-HCI [pH 
7.6], 150 mM NaCI, 0.5 mM EDTA, 1 mM EGTA, 1% SDS) containing a 
cocktail of protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 
i~g/ml pepstatin A, 5 p.g/ml eupetin, 2 ~g/ml aprotinin) and heated at 
90°C for 20 rain. The lysate was then centrifuged for 20 min in a 
microfuge at 4°C. The final supernatant was transferred to a fresh 
tube, snap frozen in dry ice, and stored at -80°C. For Western blots, 
proteins were separated on 10% SDS-PAGE gels using the Bio-Rad 
mini Protean II electrophoresis ystem. Extract was usually loaded at 
7.5-15 p_g per lane. After SDS-PAGE, the proteins were blotted onto 
Hybond-ECL nitrocellulose using a Bio-Rad minitransblot electropho- 
retic transfer cell. Different members of the Jun and Fos family were 
detected with affinity purified rabbit polyclonal antibodies as described 
by Pfarr et al. (1994) using a horseradish peroxidase-conjugated anti- 
rabbit secondary antibody and the ECL system (Amersham). The Jun 
and Fos antibodies were raised against fusions between glutathione-S- 
transferase and small portions of the coding sequences from the 
mouse Jun and Fos proteins and were affinity purified (Pfarr et al., 
1994; D. Lallemand et al., unpublished data). 
For immunofluorescence experiments, neurons grown on glass cov- 
erslips coated with poly-L-lysine and laminin were rinsed in PBS, fixed 
in 3% paraformaldehyde for 20 min at room temperature, rinsed again 
with PBS, and perrneabilized with 0.5% Triton X-100 in PBS for 5 rain 
at room temperature. Blocking and antibody incubations were then 
carried out by standard procedures (Harlow and Lane, 1988). Primary 
and secondary antibodies were diluted in 1% bovine serum albumin 
in PBS. To detect c-Jun in immunofluorescence experiments, an affin- 
ity-purified rabbit polyclonal antibody was used (Pfarr et aL, 1994). 
15-galactosidase was detected with a monoclonal antibody from Pro- 
rnega, diluted 1:400. FLAGA 169 was detected with the M2 monoclonal 
antibody (IBI Kodak) diluted 1:200. Bcl-2 was detected with a mono- 
clonal antibody (clone 124) diluted 1:80 (DAKO). Fluorescein-conjugated 
goat anti-mouse and anti-rabbit secondary antibodies were from Jack- 
son Labs and were diluted 1:100. After the secondary antibody incuba- 
tion, the cells were rinsed in PBS and the nuclei stained with Hoechst 
dye (H 33342) at 1 p,g/ml in water and then given a final rinse with 
water. Coverslips were mounted in Citifluor. The slides were viewed on 
a Nikon Microphot FXA fluorescence microscope. Kodak ektachrome 
panther 400X and TMAX (TMY400) films were used for color and black 
and white photographs, respectively. 
Plasmid Constructions 
Expression Vectors 
The murine c-Jun and bcl-2 cDNAs and the c-Jun dominant negative 
mutant FLAGA 169 were all cloned into the expression vector pCDNA1 
(Invitrogen) for microinjection experiments. In pCDNA1, transcription 
is driven by the strong CMV immediate early promoter. To construct 
pCDc-Jun, a HindllI-Pstl fragment containing the leader sequence of 
the ~-globin RNA upstream of the murine c-Jun coding sequence was 
subcloned into pCDNA1 from the plasmid T7 ~ c-Jun (Hirai et al., 
1989). pCDFLAGA 189 was constructed in two steps. The plasmid T7 
c-Jun A169 (Hirai et al., 1989) was digested with Ncol and Pstl, 
treated with phosphatasa, and the fragment containing the vector and 
[3-globin leader sequence was purified by agarose gel electrophoresis. 
This vector fragment was then ligated to a double-stranded linker oligo- 
nucleotide with Ncol and Accl ends containing an optimized ATG fol- 
lowed by the 8 amino acid FLAG apitope (AspTyrLysAspAspAspAs- 
pLys) and c-Jun sequences from amino acid 169 to 172, together with 
an AccI-Pstl fragment containing c-Jun sequences from amino acid 
173 to 334. This generated the plasmid T7 ~ FLAGA 169. The sequence 
of the linker oligo was as follows: 5'-CATGGACTACAAGGACGAC- 
GACGACAAGGAGCCTCCGGT-3' (upper strand) and 5-AGACCG- 
GAGGCTCCTTGTCGTCGTCGTCCI-I'GTAGTC-3' (lower strand). The 
HindllI-Pstl fragment from T7 ~ FLAGA169 containing the FLAG- 
tagged c-Jun A169 deletion mutant was then subclcned into pCDNA1. 
pCDbcl-2 was constructed by subcloning a HindllI-EcoRI fragment 
containing the murine bcl-2 cDNA (Nunez et al., 1990) into pCDNA1. 
The structure of all plasmid constructs was verified by direct sequenc- 
ing using a primer that hybridized to the T7 promoter in pCDNA1 and 
a USB Sequenase version 2.0 kit. The expression vectors were also 
transcribed in vitro with T7 polymerase and the resulting RNAs trans- 
lated in a TnT rabbit reticulocyte lysate system (Promega) to check 
that proteins of the correct size were made. CMV lacZ contains the 
E. coil ~-galactosidase gene under the control of the CMV immediate 
early promoter (Alberts et al., 1994). 
Reporter Genes 
The AP-1 reporter gene TRElacZ contains four copies of the collagen- 
ase gene TRE cloned upstream of a Rous sarcoma virus minimal 
promoter linked to the E. coil ~-galactosidase gene (Albarts et al., 
1993). 
Microinjection 
For microinjection, neurons were plated on glass coverslips coated 
with poly-L-lysine and laminin. Microinjection was carried out using a 
Zeiss Axiovart 135M microscope with an Eppandorf transjector (5171) 
and micromanipulator (5246). Microinjection needles were pulled from 
glass capillaries using a horizontal electrode puller (Camden Instru- 
ments, Model 773) and loaded using Eppendorf microloaders. DNA 
was injected directly into the nucleus. The expression vectors 
CMVlacZ, pCDc-Jun, pCDFLAGA169, and pCDbcl-2 were injected in 
0.5x PBS at a concentration of 0.05-0.2 mg/ml. The reporter gene 
TRElacZ was injected at 0.2 mg/ml. Approximately 400/0-80O/o f SCG 
neurons survived microinjection. Immunofluorascenca analysis was 
carried out to verify that ~-galactosidase, c-Jun, FLAGA169, or Bcl-2 
protein were expressed and correctly localized within neurons after 
injection of the appropriate xpression vectors. For these experiments, 
purified guinea pig IgG (Sigma) was added to the injection mix at a 
final concentration of 5 mg/ml. After injection, the neurons were fixed 
and stained with a rhodamine-conjugated onkey anti-guinea pig IgG 
antibody (Jackson Labs) diluted 1:100 to identify injected cells and 
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anti-l~-galactosidase, anti-c-Jun, anti-Bcl-2, or the M2 monoclonal anti- 
body, which detects FLAG-tagged proteins, as described above. In 
all cases, approximately 90% of the neurons that had survived injection 
expressed the appropriate protein. 
For analyzing the effect of expression vectors on neuronal survival 
in the absence of NGF, neurons were plated at a density of 8000 per 
coverslip and used 4-5 days after plating. Neutral 70,000 MW Texas 
Red dextran (Molecular Probes) was used to mark the injected cells 
in these experiments and was added to the injection mix at a final 
concentration of 20 mg/rnl. After injection, the neurons were left over- 
night and then refed with medium lacking NGF and containing the 
anti-NGF antibody. The number of Texas Red dextran-positive cells 
that had survived injection was then determined. The medium was 
changed daily, and 2-3 days after NGF withdrawal, calcein AM (Molec- 
ular Probes) was added to the medium. This is converted by the ester- 
ase activity in viable cells to calcein, which fluoresces green. Cell 
viability was assessed by counting the total number of Texas Red- 
positive cells and by noting their morphology and whether they were 
green (viable) or not. The microinjection experiments were indepen- 
dently carried out by more than one investigator, and on a number of 
occasions the slides were counted in a blinded fashion. 
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